PubMed Health⌕ Search

Biomedical subjects

G Vella

Publications and source records attributed to G Vella.

36 records · Page 2Linked to original sources

Interactive typology of the hypochondriacal patient.

Many authors agree on the idea that the affective and behavioural characteristic of a certain type of family encourages the use of the body as a primary means of communication with others. This way of communicating has usually been acquired during childhood and later, in the adult life, it appears again in the different social contests. Some authors like Alby, Levy, Baker, Parker, Lipscombe, Marcelli, Bianchi and others focus on this type of family interaction and the single characteristic of the personalities of each family member. These authors describe some relationship patterns used by hypochondriac patient such as: avoiding unpleasant situations, blaming others, adopt a sick-role as a way of controlling the relationship between existential events and somatic symptoms; relationship with physicians and the need to confirm her/himself.

Anxiety↗

Large-scale purification of plasmid DNA by anion-exchange high-performance liquid chromatography.

Numerous methods have previously been reported for the final steps in the large-scale purification of plasmid DNA. Although gel permeation and reverse-phase high-performance liquid chromatography have been utilized for this procedure in the past, the limited capacity of these systems often necessitated multiple rounds of chromatography, especially with the high copy number plasmids commonly in use today. In this paper, the use of the high-capacity, high-resolution Protein-Pak DEAE 8HR column is presented for the large-scale isolation of highly purified plasmid DNA from crude E. coli cell lysates. Up to 5 mg of plasmid DNA have been purified in a single 50-minute chromatography run. The purified DNA demonstrated excellent biological activity as demonstrated by restriction endonuclease digestion, E. coli transformation and DNA-mediated gene transfection of eukaryotic cells.

Biotechnology↗

Oxygen-related prostaglandin synthesis in ductus arteriosus and other vascular cells.

We compared oxygen-related prostaglandin synthesis in fetal lamb ductus arteriosus (DA) pulmonary artery (PA) and aorta endothelial and smooth muscle cells. We measured basal synthesis of 6-keto-PGF1 alpha and PGE2, the response to calcium ionophore (A23187), a nonspecific stimulus of prostaglandin production, as well as the response to oxygen, a perinatal stimulus, monitoring both the effects of hyperoxia (95% O2) and hypoxia (2% O2). In addition, we established whether differences observed in fetal lamb PA cells related to oxygen tension were also observed in newborn central and microvessel PA cells. Our results indicate that DA endothelial cells increase 6-keto-PGF1 alpha in response to ionophore (p less than 0.05). With hyperoxia, DA endothelial cells increase PGE2 synthesis and DA smooth muscle cells increase 6-keto-PGF1 alpha (p less than 0.05 and 0.02, respectively). Aorta smooth muscle cells increase 6-keto-PGF1 alpha in response to ionophore and hyperoxia (p less than 0.003 and 0.05, respectively). PA endothelial and smooth muscle cells have higher levels of basal prostaglandin synthesis when compared with DA and aorta. In response to ionophore, increased 6-keto-PGF1 alpha is observed in both PA endothelial and smooth muscle cells (p less than 0.02 and 0.0004, respectively), and PGE2 is increased in PA smooth muscle cells (p less than 0.003). Hypoxia, however, decreases PA smooth muscle production of both 6-keto-PGF1 alpha and PGE2 (p less than 0.02 and 0.01, respectively). Similar observations were made in newborn lamb central and microvessel PA cells.(ABSTRACT TRUNCATED AT 250 WORDS)

6-Ketoprostaglandin F1 alpha↗

Separation of neutral reducing oligosaccharides derived from glycoproteins by HPLC on a hydroxylated polymeric support.

A prototype hydroxylated polymeric support, Glyco-PAK N, was employed to separate a number of neutral reducing oligosaccharides derived from various glycoproteins by the hydrazinolysis/re-N-acetylation/mild acid hydrolysis procedure. General features of the separation properties of the matrix are described. A major advantage of the packing over silica-based supports is its stability, a property which is advantageous both in repetitive analytical chromatography and in the preparative isolation and spectroscopic identification of pure compounds, free of column breakdown products.

Acetonitriles↗

Bipyridine derivatives lower arteriolar resistance and improve left ventricular function in newborn lambs.

Milrinone may be used in the treatment of pulmonary hypertensive diseases of the newborn. We have studied its effects in chronically instrumented newborn lambs over a dose range from 1-100 micrograms/kg. These actions have been compared with those of amrinone. We have also tested the effect of milrinone on hypoxia and leukotriene D4-induced pulmonary vasoconstriction. Injected into the right pulmonary artery, both amrinone and milrinone cause a dose-related fall in pulmonary arteriolar resistance with milrinone being approximately 20 times more potent than amrinone and possessing an ED50 of about 10 micrograms/kg. Both agents increase left ventricular dp/dt significantly and tend to increase cardiac output. Systemic vascular resistance falls with both drugs but the change is significant only with milrinone. While milrinone attenuates the increase in pulmonary arteriolar resistance induced by leukotriene D4 and hypoxia, this is probably an indirect effect. Milrinone does not modify either the increases in left atrial, aortic pressure, and systemic vascular resistance or the decreases in cardiac output and left ventricular dp/dt induced by leukotriene D4. These findings suggest that milrinone deserves clinical trial in newborn infants with pulmonary hypertension in whom myocardial depression often coexists.

Amrinone↗

Stimulation of bovine milk galactosyltransferase activity by bovine colostrum N-acetylglucosaminyltransferase I.

Purified bovine milk galactosyltransferase was stimulated by purified bovine colostrum N-acetylglucosaminyltransferase I by more than 10-fold. Only slight stimulation of the N-acetylglucosaminyltransferase I by galactosyltransferase was observed. Heat inactivation destroyed the ability of the N-acetylglucosaminyltransferase I to stimulate the galactosyltransferase. The stimulation of galactosyltransferase was accompanied by a decrease in Km of this enzyme from 9.7 to 3.3. mM and an increase in Vmax from 1.87 to 3.71 nmol galactose transferred/min per mg galactosyltransferase when GlcNAc was the substrate. When the Km for UDPgalactose was determined, it increased from 0.19 to 0.42 mM in the presence of N-acetylglucosaminyltransferase I and the Vmax increased from 0.66 to 2.76 nmol galactose transferred/min per mg galactosyltransferase. In phosphatidylcholine vesicles, no effect on Km values with GlcNAc as substrate was noted, while an increase in the Km of UDPgalactose was observed. The Vmax values were generally higher in the lipid vesicles. Complex formation between galactosyltransferase and N-acetylglucosaminyltransferase I was demonstrated both by glycerol density gradient centrifugation and Bio-Gel P-100 column chromatography. An approximate molecular weight for the complex was obtained on a calibrated Sephadex G-200 column and found to be about 75 000, consistent with a 1:1 complex. The stimulation of galactosyltransferase involved the N-acetyllactosamine synthetase activity of this enzyme and not the lactose synthetase activity, since the latter activity was only slightly affected. Since N-acetylglucosaminyltransferase I is not involved in the lactose synthetase reaction, the stimulation is consistent with the known biosynthetic role of N-acetylglucosaminyltransferase I in the biosynthesis of asparagine-linked oligosaccharides.

Animals↗

[Target symptoms in the utilization of antidepressants].

The authors intend to bring their contribution to the controversial question of target symptoms in the use of antidepressants. An extensive literature is analyzed, and, for comparative purposes, only works in double blind are chosen that use a specific rating scale (H.D.R.S.) in such a way as to obtain results referable to homogeneous symptoms on the phenomenal level and therefore qualitatively comparable among themselves. Each item of the H.D.R.S. is compared to the target symptom only if the relative score shows a statistically significant decrease, not only in comparison to the length of treatment, but above all in comparison with other antidepressants. On the grounds of the data obtained from this methodology, it is postulated that the relation between the action of a drug and the positive response to treatment is not to be placed in comparison with phenomenal traits, but in comparison with psychopathological processes that would make up the effective targets of the action of a drug.

Adjustment Disorders↗

Control of branching during the biosynthesis of asparagine-linked oligosaccharides.

Many mammalian and avian complex carbohydrates (glycoproteins and glycolipids) have highly branched oligosaccharides. Although the function of complex carbohydrates is not known, there is evidence to suggest that oligosaccharide branching may be an important factor in the process by which cells recognize one another and their environment. Asparagine-linked (N-glycosyl) oligosaccharides can be subdivided into at least 12 classes according to their branching patterns. It is presently believed that these classes all stem from a common precursor oligosaccharide containing three D-glucose, nine D-mannose, and two N-acetyl-D-glucosamine residues. This precursor is incorporated into the protein backbone in the rough endoplasmic reticulum and is then processed within the endoplasmic reticulum and Golgi apparatus by a series of highly specific glycosidases and glycosyltransferases to yield the various classes of N-glycosyl oligosaccharides. The branches that occur in N-glycosyl oligosaccharides are usually initiated by the incorporation of a N-acetylglucosamine (GlcNAc) residue. Our laboratory has studied four of the N-acetylglucosaminyltransferases (GlcNAc-transferases) involved in this initiation process. We have defined various factors which determine the synthetic pathway. There are at least three types of control that are commonly found. (i) Tissues differ in the relative activities of the different glycosyltransferases and glycosidases and, therefore, competition between two or more enzymes for a common intermediate often determines the synthetic route. (ii) The incorporation of a key glycosyl residue into an oligosaccharide may convert a nonsubstrate to a substrate for either a glycosyltransferase or a glycosidase. (iii) Conversely, the incorporation of a key residue may convert a substrate into a nonsubstrate. Other controls are undoubtedly operative during glycoprotein synthesis: e.g., the effect of the polypeptide sequence on transferase specificity, the distribution of transferases along the endomembrane system, and compartmentation and the availability of substrates and cofactors. These factors have not been studied in our laboratory. However, the oligosaccharides made by the hen oviduct correlate quite well with the control factors elucidated by our approach; other tissues are presently under investigation. Recent studies on the three-dimensional structures of N-glycosyl oligosaccharides have enabled us to explain certain features of glycosyltransferase substrate specificity on the basis of steric factors.

Animals↗

Systematic development and validation of sanitization protocols for a chromatographic system designed for biotherapeutics purification.

Production of protein therapeutics through the application of genetic engineering and biotechnology techniques requires comprehensive attention to good manufacturing practice and good laboratory practice (GMP/GLP) guidelines for product recovery and purification. Validated clean-in-place procedures are part of the master method and require analysis of microbial bioburden to assess the efficacy of cleaning protocols. This article describes the extensive microbial challenge of a chromatography system, the use of membrane filtration methods for high sensitivity microbial contamination measurement, and the effectiveness of sodium hydroxide and ethanol solutions in achieving multilog reduction of microbial contamination.

Acholeplasma laidlawii↗

The complexity of psychiatric comorbidity: a conceptual and methodological discussion.

Comorbidity is widely used in psychiatry, although few studies have considered the conceptual and methodological problems deriving from the transposition of this term from medicine to psychiatry. Comorbidity should be defined as two or more diseases, with distinct aetiopathogenesis (or, if the aetiology is unknown, with distinct pathophysiology of organ or system), that are present in the same individual in a defined period of time. In psychiatry, comorbidity is often an artefact for several reasons: (a) different assessment methods; (b) improper utilisation of the term comorbidity to indicate the association of symptoms instead of diseases; (c) number and characteristics of hierarchical exclusion rules used in classification systems; (d) nosologic classification in disorders (a generic term) instead of syndromes (a more precise concept, that allows clinicians to consider the hierarchy and the qualitative specificity of symptoms); (e) excessive splitting of classical syndromes into small disorders with inappropriate and overlapping boundaries; (f) too frequent revision of the diagnostic criteria, that changes diagnostic threshold; (g) number of clinical entities considered. Biological and psychological hypotheses that investigate the complexity of comorbidity findings are here presented; it is underlined that comorbidity should be the epidemiological descriptive starting point to build hypotheses that must be clear and rigorously defined, with specified usefulness and limits. Finally, the hypotheses should be tested with specific methodologies.

Comorbidity↗